US Patent Issued to BIONEER on Aug. 4 for "CTGF gene-specific double-stranded oligonucleotide, and a composition for preventing and treating fibrotic diseases and respiratory-related diseases comprising same" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,500, issued on Aug. 4, was assigned to BIONEER Corp. (Daejeon, South Korea).

"CTGF gene-specific double-stranded oligonucleotide, and a composition for preventing and treating fibrotic diseases and respiratory-related diseases comprising same" was invented by Han-Oh Park (Sejong-si, South Korea), Tae-Rim Kim (Daejeon, South Korea), Young-Ho Ko (Daejeon, South Korea), Sung Il Yun (Daejeon, South Korea) and Jun Hong Park (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a double-stranded oligonucleotide capable of inhibiting CTGF expression with a very specific and high efficiency, a double-stranded o...